For research use only. Not for therapeutic Use.
QD232(CAT: I035306) is a small-molecule inhibitor designed to target specific signaling pathways, with potential applications in cancer and cellular biology research. It is particularly valuable for studying the mechanisms underlying cellular proliferation, apoptosis, and signal transduction in tumor cells. By selectively inhibiting its target, QD232 disrupts critical molecular interactions, offering insights into the development of targeted therapies. With high specificity, stability, and activity, QD232 is suitable for in vitro and in vivo studies, providing researchers with a reliable tool to explore therapeutic strategies for oncology and other diseases linked to dysregulated cellular signaling.
Catalog Number | I035306 |
CAS Number | 1527467-32-8 |
Synonyms | QD232; QD 232; QD-232; |
Molecular Formula | C16H11N3O3 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
IUPAC Name | 6-((3-acetylphenyl)amino)quinazoline-5,8-dione |
InChI | InChI=1S/C16H11N3O3/c1-9(20)10-3-2-4-11(5-10)19-13-6-14(21)15-12(16(13)22)7-17-8-18-15/h2-8,19H,1H3 |
InChIKey | ISLYLVODAYGJNW-UHFFFAOYSA-N |
SMILES | O=C(C(NC1=CC=CC(C(C)=O)=C1)=C2)C3=CN=CN=C3C2=O |